المؤلفون: Ma Y; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China. mayuan@hkbu.edu.hk.; Increasepharm & Hong Kong Baptist University Joint Centre for Nucleic Acid Drug Discovery, Hong Kong Science Park, New Territoreis, Hong Kong SAR, 999077, China. mayuan@hkbu.edu.hk., Xie D; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China., Chen Z; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China.; Increasepharm & Hong Kong Baptist University Joint Centre for Nucleic Acid Drug Discovery, Hong Kong Science Park, New Territoreis, Hong Kong SAR, 999077, China., Shen X; Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China., Wu X; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China., Ding F; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China., Ding S; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China., Pan Y; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China., Li F; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China.; Increasepharm & Hong Kong Baptist University Joint Centre for Nucleic Acid Drug Discovery, Hong Kong Science Park, New Territoreis, Hong Kong SAR, 999077, China., Lu A; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China. aipinglu@hkbu.edu.hk., Zhang G; Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tsai, Hong Kong SAR, 999077, China. zhangge@hkbu.edu.hk.

المصدر: Journal of translational medicine [J Transl Med] 2024 Jul 01; Vol. 22 (1), pp. 604. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Aptamers, Nucleotide*/pharmacology , Aptamers, Nucleotide*/chemistry , Paclitaxel*/therapeutic use , Paclitaxel*/pharmacology , Nucleolin* , Fluorouracil*/pharmacology , Fluorouracil*/therapeutic use , Drug Liberation* , RNA-Binding Proteins*/metabolism , Delayed-Action Preparations* , Phosphoproteins*/metabolism, Humans ; Cell Line, Tumor ; Animals ; Female ; Oligodeoxyribonucleotides/pharmacology ; Oligodeoxyribonucleotides/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Mice, Nude ; Xenograft Model Antitumor Assays ; Cell Proliferation/drug effects ; Oxidation-Reduction/drug effects ; Mice, Inbred BALB C

المؤلفون: Hirose T; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Gastroenterology, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Yamamoto S; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Honma Y; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yokoyama K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Hirano H; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Okita N; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shoji H; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Iwasa S; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Takashima A; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Ishiyama K; Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan., Oguma J; Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan., Daiko H; Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan., Maeda S; Department of Gastroenterology, Graduate School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Kato K; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kenkato@ncc.go.jp.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. kenkato@ncc.go.jp.

المصدر: Esophagus : official journal of the Japan Esophageal Society [Esophagus] 2024 Jul; Vol. 21 (3), pp. 328-335. Date of Electronic Publication: 2024 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Japan NLM ID: 101206627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1612-9067 (Electronic) Linking ISSN: 16129059 NLM ISO Abbreviation: Esophagus Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/surgery , Esophagogastric Junction*/pathology , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use , Docetaxel*/administration & dosage , Docetaxel*/therapeutic use , Cisplatin*/administration & dosage , Cisplatin*/therapeutic use , Adenocarcinoma*/drug therapy , Adenocarcinoma*/pathology , Adenocarcinoma*/surgery , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage, Humans ; Male ; Middle Aged ; Aged ; Female ; Retrospective Studies ; Adult ; Aged, 80 and over ; Japan/epidemiology ; Esophagectomy/methods ; Treatment Outcome ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Neoadjuvant Therapy/methods

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Teixeira AS; Department of Dermatology, Instituto Lauro de Souza Lima, Bauru, SP, Brazil. Electronic address: dermatologia@ilsl.br., Martins IMC; Department of Infectology, Dermatology, Radiotherapy and Diagnostic Imaging, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil., Miola AC; Department of Infectology, Dermatology, Radiotherapy and Diagnostic Imaging, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil. Electronic address: anna.c.miola@unesp.br., Miot HA; Department of Infectology, Dermatology, Radiotherapy and Diagnostic Imaging, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil.

المصدر: Anais brasileiros de dermatologia [An Bras Dermatol] 2024 Jul-Aug; Vol. 99 (4), pp. 527-534. Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier España, S.L Country of Publication: Spain NLM ID: 0067662 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1806-4841 (Electronic) Linking ISSN: 03650596 NLM ISO Abbreviation: An Bras Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Fluorouracil*/administration & dosage , Fluorouracil*/adverse effects , Fluorouracil*/therapeutic use , Colchicine*/administration & dosage , Colchicine*/adverse effects , Colchicine*/therapeutic use , Keratosis, Actinic*/drug therapy , Skin Cream*/administration & dosage, Humans ; Male ; Female ; Aged ; Treatment Outcome ; Middle Aged ; Aged, 80 and over ; Administration, Cutaneous ; Antimetabolites, Antineoplastic/administration & dosage ; Antimetabolites, Antineoplastic/adverse effects ; Antimetabolites, Antineoplastic/therapeutic use ; Severity of Illness Index ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Time Factors

المؤلفون: Tu X; Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, No. 74, Linjiang Road, Yuzhong District, Chongqing Municipality, 400010, People's Republic of China., Zhang W; Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, No. 74, Linjiang Road, Yuzhong District, Chongqing Municipality, 400010, People's Republic of China., Li S; Department of Hepatobiliary Pancreatic Tumor Center, Chongqing University Cancer Hospital, Chongqing, No. 181, Hanyu Road, Shapingba District, Chongqing Municipality, 400010, People's Republic of China., He Q; Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, No. 74, Linjiang Road, Yuzhong District, Chongqing Municipality, 400010, People's Republic of China., Li Y; Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, No. 74, Linjiang Road, Yuzhong District, Chongqing Municipality, 400010, People's Republic of China. 300385@hospital.cqmu.edu.cn.

المصدر: European journal of medical research [Eur J Med Res] 2024 Sep 19; Vol. 29 (1), pp. 465. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 9517857 Publication Model: Electronic Cited Medium: Internet ISSN: 2047-783X (Electronic) Linking ISSN: 09492321 NLM ISO Abbreviation: Eur J Med Res Subsets: MEDLINE

مواضيع طبية MeSH: Liver Neoplasms*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Portal Vein*/pathology , Infusions, Intra-Arterial* , Fluorouracil*/administration & dosage , Fluorouracil*/adverse effects , Oxaliplatin*/administration & dosage , Oxaliplatin*/therapeutic use , Oxaliplatin*/adverse effects , Organoplatinum Compounds*/administration & dosage , Organoplatinum Compounds*/therapeutic use , Venous Thrombosis*/drug therapy , Venous Thrombosis*/etiology , Leucovorin*/administration & dosage , Leucovorin*/therapeutic use , Leucovorin*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Hepatic Artery ; Thiophenes/administration & dosage ; Thiophenes/therapeutic use ; Quinazolines/administration & dosage ; Quinazolines/therapeutic use ; Quinazolines/adverse effects ; Retrospective Studies ; Chemoembolization, Therapeutic/methods

SCR Protocol: Folfox protocol

المؤلفون: Bai SR; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China., Zhao BX; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China., Zhao Q; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China., Ge YC; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China., Li M; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China., Zhao CG; Microbiology Research Institute, Guangxi Academy of Agricultural Science, Nanning, 530007, Guangxi Province, China., Wu XJ; Microbiology Research Institute, Guangxi Academy of Agricultural Science, Nanning, 530007, Guangxi Province, China. 494179474@qq.com., Wang XB; School of Basic Medicine, Dali University, Dali, 671000, Yunnan, China. wxb4320062@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Sep 19; Vol. 14 (1), pp. 21852. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Oleanolic Acid*/pharmacology , Fluorouracil*/adverse effects , Fluorouracil*/pharmacology , Cellular Senescence*/drug effects , Inflammation*/drug therapy , Inflammation*/pathology , Inflammation*/metabolism , Human Umbilical Vein Endothelial Cells*/drug effects, Humans ; Animals ; Mice ; Intestinal Mucosa/drug effects ; Intestinal Mucosa/metabolism ; Intestinal Mucosa/pathology ; Mice, Inbred BALB C ; Intestines/drug effects ; Intestines/pathology ; Male ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology

المؤلفون: Sun L; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Hu Z; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Xie W; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Yang Z; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Zeng H; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Zhang Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Chen M; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China., Hu D; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China. hudd@sysucc.org.cn.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hudd@sysucc.org.cn.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. hudd@sysucc.org.cn., Zhou Z; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China. zhouzhg@sysucc.org.cn.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. zhouzhg@sysucc.org.cn.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. zhouzhg@sysucc.org.cn., Pan Y; Department of Liver Surgery, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, People's Republic of China. panyx@sysucc.org.cn.; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. panyx@sysucc.org.cn.; Guangdong Provnvial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. panyx@sysucc.org.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Sep 19; Vol. 24 (1), pp. 1168. Date of Electronic Publication: 2024 Sep 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/mortality , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Leucovorin*/therapeutic use , Leucovorin*/administration & dosage , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Organoplatinum Compounds/therapeutic use ; Organoplatinum Compounds/administration & dosage ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/adverse effects ; Infusions, Intra-Arterial ; Oxaliplatin/administration & dosage ; Oxaliplatin/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects

SCR Protocol: Folfox protocol

المؤلفون: Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kotani D; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Satake H; Department of Medical Oncology, Kochi Medical School/Kansai Medical University, Nankoku, Japan. Electronic address: takeh1977@gmail.com., Hamaguchi T; Department of Gastroenterological Oncology, Saitama Medical University International Medical Center, Saitama, Japan., Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan., Kotaka M; Gastrointestinal Cancer Center, Sano Hospital, Hyogo, Japan., Masuishi T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan., Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Hyogo, Japan., Kagawa Y; Department of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Japan., Komatsu Y; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan., Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Yamamoto Y; Department of Gastroenterology, University of Tsukuba Hospital, Ibaraki, Japan., Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osakasayama, Japan., Misumi T; Department of Data Science, National Cancer Center Hospital East, Kashiwa, Japan., Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan., Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kato T; Department of Surgery, NHO Osaka National Hospital, Osaka, Japan., Tsuji A; Department of Medical Oncology, Kagawa University Hospital, Kagawa, Japan.

المصدر: Med (New York, N.Y.) [Med] 2024 Sep 13; Vol. 5 (9), pp. 1164-1177.e3. Date of Electronic Publication: 2024 Jun 19.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

مواضيع طبية MeSH: Bevacizumab*/administration & dosage , Bevacizumab*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/mortality , Colorectal Neoplasms*/pathology , Leucovorin*/therapeutic use , Leucovorin*/administration & dosage , Leucovorin*/adverse effects , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use , Fluorouracil*/adverse effects , Organoplatinum Compounds*/therapeutic use , Organoplatinum Compounds*/administration & dosage, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Capecitabine/administration & dosage ; Capecitabine/therapeutic use ; Capecitabine/adverse effects ; Progression-Free Survival ; Oxaliplatin/administration & dosage ; Oxaliplatin/therapeutic use ; Oxaliplatin/adverse effects ; Camptothecin/analogs & derivatives ; Camptothecin/administration & dosage ; Camptothecin/therapeutic use ; Camptothecin/adverse effects ; Irinotecan/therapeutic use ; Irinotecan/administration & dosage ; Irinotecan/adverse effects

SCR Protocol: FOLFOXIRI protocol

المؤلفون: Boisteau E; Department of Gastroenterology, University Hospital Pontchaillou, Rennes 1 University, INSERM U1242 'Chemistry Oncogenesis Stress Signalling,' Rennes, France., Dahan L; Department of Digestive Oncology, La Timone, AMU, Marseille, France., Williet N; Hepatogastroenterology Department, University Hospital of Saint-Etienne, Saint-Etienne, France., Le Malicot K; Biostatistics Department, Francophone Federation of Digestive Cancerology, EPICAD INSERM LNC-UMR 1231 University of Burgundy and Franche Comté, Dijon, France., Desramé J; Jean Mermoz Private Hospital, Lyon, France., Bouché O; Department of Digestive Oncology, CHU Reims, Reims, France., Petorin C; Department of Digestive Oncology, University Hospital d'Estaing, Clermont-Ferrand, France., Malka D; Department of Hepato-Gastroenterology, Gustave Roussy Cancer Campus, Villejuif, France., Rebischung C; Savoie Medipole, Challes-Les-Eaux, France., Aparicio T; Department of Gastroenterology, Saint Louis Hospital, APHP, Université de Paris, Paris, France., Lecaille C; Oncology Department, Polyclinique Nord, Bordeaux, France., Rinaldi Y; Department of Hepato-gastroenterology, European Hospital, Marseille, France., Turpin A; Univ. Lille, CNRS UMR9020, Inserm UMR-S 1277, Canther, Cancer Heterogeneity, Plasticity and Resistance to Therapies, CHU Lille, Department of Medical Oncology, Lille, France., Bignon AL; Department of Digestive Oncology, University Hospital Côte de Nacre, Caen, France., Bachet JB; Department of Hepato-gastroenterology, Pitié-Salpêtrière Hospital, Paris, France., Lepage C; Department of Hepato-gastroenterology, University hospital of Dijon, EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France., Granger V; Department of Hepato-gastroenterology and Digestive Oncology, University Hospital of Grenoble Alpes, Grenoble, France., Legoux JL; Department of Hepato-gastroenterology and Digestive Oncology, Orléans Regional Hospital, Orléans, France., Deplanque G; Department of Hepato-Gastroenterology, Saint-Joseph Hospital, Paris, France., Baconnier M; Department of Hepato-Gastroenterology, Annecy-Genevois Hospital Center, Epagny Metz-Tessy, France., Lecomte T; Department of Hepato-Gastroenterology and Digestive Oncology, University Hospital of Tours; UMR INSERM 1069 Nutrition, Croissance et Cancer, University of Tours, Tours, France., Bonnet I; Department of Oncology, Valenciennes, France., Seitz JF; Department of Digestive Oncology, La Timone, AMU, Marseille, France., François E; Antoine Lacassagne Center, Oncology Department, Nice, France., Lièvre A; Department of Gastroenterology, University Hospital Pontchaillou, Rennes 1 University, INSERM U1242 'Chemistry Oncogenesis Stress Signalling,' Rennes, France.

مؤلفون مشاركون: PRODIGE 35 Investigator/Collaborators

المصدر: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. e1149-e1158.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/pathology , Fluorouracil*/administration & dosage , Fluorouracil*/therapeutic use , Leucovorin*/therapeutic use , Leucovorin*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Irinotecan*/therapeutic use , Irinotecan*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Prognosis ; Quality of Life ; Oxaliplatin/therapeutic use ; Oxaliplatin/administration & dosage ; Adult ; Neoplasm Metastasis

المؤلفون: Sanoff HK; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27514, United States., Deal AM; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States., Patel J; Levine Cancer Center, Charlotte, NC 28204, United States., Sorah JD; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27514, United States., Gaddy J; Division of Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT 06520, United States., O'Neil B; Community Health System, Indianapolis, IN 46250, United States., Turk A; Division of Hematology/Oncology, Indiana University, Indianapolis, IN 46202, United States., Irvin W; Bon Secours Cancer Institute, Richmond, VA 23114, United States., Boles J; UNC Rex Hematology/Oncology, Raleigh, NC 27607, United States., Lee MS; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States., McRee A; The Janssen Research and Development, Spring House, PA 19002, United States., Wardell AC; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States., Weck KE; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27514, United States., Basch E; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States.; Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27514, United States., Wood WA; Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, United States.; Division of Hematology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27514, United States., Innocenti F; Division of Pharmacotherapy and Experimental Therapeutics, Eschelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27514, United States.

المصدر: The oncologist [Oncologist] 2024 Sep 06; Vol. 29 (9), pp. 786-793.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Bevacizumab*/administration & dosage , Bevacizumab*/pharmacology , Bevacizumab*/therapeutic use , Bevacizumab*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacology , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Glucuronosyltransferase*/genetics , Leucovorin*/administration & dosage , Leucovorin*/therapeutic use , Leucovorin*/adverse effects , Camptothecin*/analogs & derivatives , Camptothecin*/therapeutic use , Camptothecin*/administration & dosage , Camptothecin*/adverse effects , Camptothecin*/pharmacology , Fluorouracil*/administration & dosage , Fluorouracil*/adverse effects , Fluorouracil*/therapeutic use , Genotype*, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Irinotecan/administration & dosage ; Irinotecan/therapeutic use ; Irinotecan/adverse effects ; Irinotecan/pharmacology

SCR Protocol: IFL protocol

المؤلفون: Guo Y; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China., Zhong W; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China., Peng C; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China., Guo L; State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.; School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 05; Vol. 25 (17). Date of Electronic Publication: 2024 Sep 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Photochemotherapy*/methods , Apoptosis*/drug effects , Melanoma*/drug therapy , Melanoma*/pathology , Fluorouracil*/pharmacology , Fluorouracil*/administration & dosage , Cell Cycle Checkpoints*/drug effects , Photosensitizing Agents*/pharmacology , Photosensitizing Agents*/administration & dosage, Animals ; Humans ; Mice ; Cell Line, Tumor ; Mice, Nude ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Reactive Oxygen Species/metabolism ; Xenograft Model Antitumor Assays ; Administration, Topical ; Furocoumarins/pharmacology ; Furocoumarins/administration & dosage ; Furocoumarins/chemistry